ArticleInflammatory bowel diseases2023

Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.

Gary R Lichtenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.